Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cybin Inc
N.CYBN
Alternate Symbol(s):
CYBN
Healthcare
Drug Manufacturers - Specialty & Generic
Psychedelics
Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N,N-dimethyltryptamine (DMT) and dDMT programs creates a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary...
deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II. It has an intellectual property portfolio in the psychedelic drug development sector with over 30 patents granted and 160 patents pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands and Ireland.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NEO:CYBN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
Next
(0)
•••
hgdcybn
X
View Profile
View Bullboard History
Post by
hgdcybn
on Apr 29, 2021 11:18am
Sharing this post from The Motley Fool on Cybin
Forget Sundial Growers: Put This Stock on Your Radar
(4)
•••
Catmando123
X
View Profile
View Bullboard History
Post by
Catmando123
on Apr 28, 2021 3:37pm
Q1 Earnings Release _ HOLL
Expecting a 2-% pop by Friday - please feel free to do your own DD
(0)
•••
hgdcybn
X
View Profile
View Bullboard History
Post by
hgdcybn
on Apr 28, 2021 2:51pm
Great volume on the stock today
Great volume on the stock today. Over 7 million shares traded already.
(0)
•••
hgdcybn
X
View Profile
View Bullboard History
Post by
hgdcybn
on Apr 28, 2021 1:10pm
US$10 per share price target from Roth Capital for Cybin
just sharing this US$10 per share price target from Roth Capital on Cybin. This along side MMED Nasdaq listing is great for the industry. https://drive.google.com/file/d/17ehc
...more
(0)
•••
TrojanHorse82
X
View Profile
View Bullboard History
Post by
TrojanHorse82
on Mar 29, 2021 12:36am
Breakthrough Tech to Measure Real-Time Brain Activity
Cybin (NEO: CYBN) (OTC: CLXPF), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, recently announced its collaboration with neurotech
...more
(0)
•••
TrojanHorse82
X
View Profile
View Bullboard History
Post by
TrojanHorse82
on Mar 29, 2021 12:34am
Cybin News
To view the full editorial, please visit: https://nnw.fm/3IBl7 Psilocybins are a hallucinogenic substance found in certain types of mushroom, dubbed magic mushrooms, and used for centuries by
...more
(0)
•••
TrojanHorse82
X
View Profile
View Bullboard History
Post by
TrojanHorse82
on Mar 29, 2021 12:31am
Cybin Inc. Announces Completion of 20th Preclinical Study
Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has announced completion of its 20th preclinical study and is progressing its CYB003 and
...more
(0)
•••
TrojanHorse82
X
View Profile
View Bullboard History
Post by
TrojanHorse82
on Mar 29, 2021 12:28am
Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Enters Strategic Drug
Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, today announced its entry into a drug development agreement with Catalent (NYSE: CTLT), the
...more
(182)
•••
Chritters
X
View Profile
View Bullboard History
Post by
Chritters
on Mar 10, 2021 10:26am
Just came across this company
I am currently with BUZZ and TRIP(Trip I want out of) what are the differences with all these companies
(11)
•••
panafly
X
View Profile
View Bullboard History
Post by
panafly
on Feb 04, 2021 1:56pm
On sale
You can get in rigth now cheaper than the Instutions.
(11)
•••
panafly
X
View Profile
View Bullboard History
Post by
panafly
on Feb 04, 2021 9:43am
HUGE
This is huge for CYBN. The best in the biz!
(21)
•••
Clementson
X
View Profile
View Bullboard History
Post by
Clementson
on Jan 26, 2021 12:49pm
Fueling the fire
Sponsored Post: Global CB market could soon be worth approximately $89 billion! Isn't that something good to look over for yourself? Legalization proposals could now be on track and
...more
(16)
•••
BillyKnowsBest
X
View Profile
View Bullboard History
Post by
BillyKnowsBest
on Jan 26, 2021 12:42pm
3 Reasons to Buy MMED
Full disclosure MMED is the only company I have an interest in currently in the psychedelic sector, and here are a few points as to why they are the horse I'm backing Clinical Trials team
...more
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Jan 19, 2021 9:17am
Cybin Upsizes Bought Deal Financing To $30.0 Million
Cybin Inc has upsized its previously announced $20.0 million bought deal financing. The financing, following strong investor demand, has now been upsized to $30.0 million. https://thedeepdive.ca
...more
(15)
•••
realitycheck00
X
View Profile
View Bullboard History
Post by
realitycheck00
on Jan 19, 2021 8:48am
$30M more cash in the bank for Cybin
This should take them to $70M+ cash in the bank and from warrant conversions close to $85M. https://www.newswire.ca/news-releases/cybin-announces-upsize-to-previously-announced-bought
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Do you want to stay ahead of the markets? See how DealRoom can help.